** Shares of medical device maker Neuropace NPCE.O fall 16.54% to $10.09
** Co announces the pricing of $65 million of common stock
** Co plans to offers 6.5 million shares at a public offering price of $10.00 per share; 17.3% discount to last closing price
** Grants underwriters a 30-day option to purchase up to an additional 975,000 shares of its common stock at the public offering price
** The offering is expected to close on February 18
** Co has 29.85 mln shares outstanding, giving it a ~360 mln market cap - data compiled from LSEG
** The stock has fallen ~27% in the last 12 months
(Reporting by Siddhi Mahatole)
((Siddhiprabhanjan.mahatole@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.